Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Addition of Chloroquine to Chemoradiation for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
DC Migration Study for Newly-Diagnosed GBM
- Status
- COMPLETED
- Phase
- PHASE2
Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE4
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
- Status
- COMPLETED
- Phase
- PHASE2
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
- Status
- TERMINATED
- Phase
- N/A